跳至主要内容
临床试验/NCT04037072
NCT04037072撤回2 期

GI-108: Randomized Controlled Double-Blinded Trial Assessing the Efficacy of Topical Mitomycin C for Complex Benign Esophageal Anastomotic Strictures

Fox Chase Cancer Center1 个研究点 分布在 1 个国家开始时间: 2020年4月3日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
撤回
试验地点
1
主要终点
Rate of dysphagia ≥ grade 1 after the dilation procedure

研究概览

简要总结

This study evaluates Mitomycin C as treatment for dysphagia in adult subjects with documented complex esophageal anastomotic strictures. Patients will be randomized in a double-blinded fashion to topical application of normal saline (NS) or Mitomycin C (MMC) at the time of time of index procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Ability to understand and willingness to sign a written informed consent and HIPAA consent document
  • Patients must have symptomatic (dysphagia ≥2), treatment naïve complex esophageal anastomotic stricture (length >2 cm or diameter ≤9mm).
  • Esophago-gastro or esophago-jejunal anastomosis with or without having undergone neoadjuvant or adjuvant radio-chemotherapy
  • Any patient taking antiplatelet agents such as Plavix, Effient, Brilinta, Aggrenox must be able to hold the drugs 5 days prior to dilation and may resume 3 days after the dilation.
  • Any patient on vitamin K antagonists such as warfarin must be able to hold the drugs 5 days prior to dilation and may resume 3 days after the dilation. INR should be checked for such patients at least 24 hours before dilation and it must be < 1.5
  • Patients taking direct thrombin inhibitors such as Pradaxa, Angiomax must be able to hold the drugs 5 days prior to dilation and may resume 3 days after the dilation
  • Patients taking Factor Xa inhibitors must be able to hold the drugs 2 days prior to dilation and may resume 3 days after dilation
  • Patients taking GIIB/IIIA inhibitors must be able to hold the drugs1 day prior to dilation and resume 3 days after the dilation.
  • Patients taking unfractionated heparin must be able to hold the drug 6 hours before dilation and low molecular weight heparin must be held 24 hours before dilation. Unfractionated heparin may resume immediately after the dilation while low molecular weight heparin may resume 3 days after dilation

排除标准

  • Patients with malignant strictures
  • Patients with non-complex benign strictures.
  • Patients with anastomosis creation within ≤ 2 weeks
  • Patients with suspected gastrointestinal perforation or leak that could result in extraluminal extravasation of Mitomycin C
  • Uncontrolled intercurrent illness including, but not limited to, ongoing or active infection, symptomatic congestive heart failure, unstable angina pectoris, cardiac arrhythmia, or psychiatric illness/social situations that would limit compliance with study requirements.
  • Pregnant or breast feeding. Refer to section 4.4 for further detail.
  • Patients receiving systemic chemotherapy during the treatment of esophageal stricture.

研究组 & 干预措施

Mitomycin C

Experimental

Cotton swab or strip of 2x2 cotton gauze soaked with 0.4mg/mL Mitomycin C

干预措施: Mitomycin C (Drug)

Control

Placebo Comparator

Cotton swab or strip of 2x2 cotton gauze soaked with Normal saline

干预措施: Control (Other)

结局指标

主要结局

Rate of dysphagia ≥ grade 1 after the dilation procedure

时间窗: 6 months

Prevalence of dysphagia grade ≥1 in MMC Vs normal saline treated patients until 6 months after the first follow-up.

次要结局

  • Number of procedures needed to reach dilation goal(30 days)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

Efficacy of Topical Mitomycin C for Complex Benign... | 临床试验